Literature DB >> 31912185

Using a novel MR imaging sign to differentiate retinal pigment epithelium from uveal melanoma.

Yaping Su1,2, Xiaolin Xu3,4, Wenbin Wei3,4, Junfang Xian5,6.   

Abstract

PURPOSE: Retinal pigment epithelium (RPE) adenoma is a rare intraocular benign tumor. It is almost always misdiagnosed as uveal melanoma (UM) resulting in inappropriate management. The purpose of this study was to investigate MRI features of the RPE adenoma that may help differentiate this entity from UM.
METHODS: MRI was performed in eight patients with pathology-proven RPE adenoma, five of whom had dynamic contrast-enhanced (DCE) MRI. The time-intensity curves (TIC) of all DCE-MRI were evaluated, and the maximum contrast index (CImax) were calculated.
RESULTS: All eight tumors showed well-defined margins. They were homogeneously hyperintense on T1WI and hypointense on T2WI compared to vitreous body. An oval mass was seen in five tumors, lentiform in two tumors, and placoid-shaped in one tumor. After contrast administration, mild enhancement was identified in five tumors and moderate enhancement in three tumors. In all five tumors, DCE-MRI exhibited a plateau-shaped TIC with a median CImax of 0.37. A "dark-linear sign" (defined as low signal intensity linear zone located between tumor and enhanced choroid on post contrast T1WI with fat-suppression) was noted in all eight patients with RPE adenoma.
CONCLUSION: RPE adenoma and UM often have similar MR imaging findings. This study reports for the first time a "dark-linear sign" on post contrast T1WI with fat-suppression seen in RPE adenoma. This observation may be characteristic of RPE adenoma and may help separate this entity from UM.

Entities:  

Keywords:  Adenoma; Diagnosis; Magnetic resonance imaging; Retinal pigment epithelium; Uveal melanoma

Mesh:

Substances:

Year:  2020        PMID: 31912185     DOI: 10.1007/s00234-019-02353-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Adenocarcinoma of the retinal pigment epithelium: clinicopathologic correlation with paradoxical immunohistochemical findings.

Authors:  Jerry A Shields; Ralph C Eagle; Jonathan Dutton; Hormoz Ehya; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2014-10       Impact factor: 7.389

Review 2.  Adenocarcinoma of the retinal pigment epithelium: a diagnostic and therapeutic challenge.

Authors:  P T Finger; S A McCormick; M Davidian; J B Walsh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 3.  Standardized echography: basic principles, clinical applications, and results.

Authors:  K C Ossoinig
Journal:  Int Ophthalmol Clin       Date:  1979

4.  Reliability of ocular and orbital diagnosis with B-scan ultrasound. 1. Ocular diagnosis.

Authors:  D J Coleman
Journal:  Am J Ophthalmol       Date:  1972-04       Impact factor: 5.258

5.  Adenoma of the retinal pigment epithelium: a report of 3 cases.

Authors:  Wenbin Wei; Jing Mo; Ying Jie; Bin Li
Journal:  Can J Ophthalmol       Date:  2010-04       Impact factor: 1.882

6.  Neoplasms of the retinal pigment epithelium: the 1998 Albert Ruedemann, Sr, memorial lecture, Part 2.

Authors:  J A Shields; C L Shields; K Gündüz; R C Eagle
Journal:  Arch Ophthalmol       Date:  1999-05

Review 7.  Uveal melanoma, choroidal hemangioma, and simulating lesions. Role of MR imaging.

Authors:  M F Mafee
Journal:  Radiol Clin North Am       Date:  1998-11       Impact factor: 2.303

Review 8.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

9.  Adenocarcinoma of the retinal pigment epithelium.

Authors:  D Minckler; A W Allen
Journal:  Arch Ophthalmol       Date:  1978-12

10.  Ultrasonographic features of choroidal malignant melanomas.

Authors:  D G Fuller; W B Snyder; W L Hutton; A Vaiser
Journal:  Arch Ophthalmol       Date:  1979-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.